Oncovin and Encephalitis - a phase IV clinical study of FDA data

Summary:

Encephalitis is reported as a side effect among people who take Oncovin (vincristine sulfate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Encephalitis when taking Oncovin. It is created by eHealthMe based on reports of 6,660 people who have side effects when taking Oncovin from the FDA, and is updated regularly.

What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.

What is Encephalitis?

Encephalitis (inflammation of the brain) is found to be associated with 662 drugs and 844 conditions by eHealthMe. Check the latest studies of Encephalitis.

On Jul, 11, 2026

6,660 people reported to have side effects when taking Oncovin.
Among them, 13 people (0.2%) have Encephalitis.

Among these 13 people:

How long have people been on Oncovin when they have Encephalitis? *

What is the gender of people who have Encephalitis when taking Oncovin? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Encephalitis when taking Oncovin? *

What are other drugs people take besides Oncovin? *

Cyclophosphamide: 5 people, 38.46%
Valacyclovir Hydrochloride: 3 people, 23.08%
Prednisone: 3 people, 23.08%
Etoposide: 3 people, 23.08%
Ifosfamide: 2 people, 15.38%
Pentamidine Isethionate: 2 people, 15.38%
Dacarbazine: 2 people, 15.38%
Cytarabine: 2 people, 15.38%
Melphalan: 2 people, 15.38%
Ciclosporin: 2 people, 15.38%

What are other side effects people have besides Encephalitis? *

Acanthamoeba Infection (acanthamoeba infection is a cutaneous condition): 5 people, 38.46%
Necrosis (the death of body tissue): 3 people, 23.08%
Alexia: 3 people, 23.08%
Confusion: 3 people, 23.08%
Drug Intolerance (drug sensitivity): 3 people, 23.08%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Vasogenic Cerebral Oedema (increase in brain water): 3 people, 23.08%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 23.08%
General Physical Health Deterioration (weak health status): 2 people, 15.38%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 5 people, 38.46%
Acanthamoeba Infection (acanthamoeba infection is a cutaneous condition): 3 people, 23.08%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 23.08%
Bone Marrow Conditioning Regimen: 2 people, 15.38%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 15.38%
Oedema (fluid collection in tissue): 2 people, 15.38%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 15.38%
Herpes Zoster: 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and have Encephalitis?

- Check whether Encephalitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oncovin:

Oncovin (6,667 reports)

Encephalitis treatments and more:

Encephalitis (9,372 reports)

Browse all side effects of Oncovin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalitis:

Encephalitis (663 drugs)

Browse all the conditions that are associated with Encephalitis:

Encephalitis (844 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate (the active ingredients of Oncovin) and Oncovin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.